feed,title,long_url,short_url
Benzinga,"Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive",https://benzinga.com/general/biotech/22/10/29268705/pasithea-largest-investor-group-says-allomek-therapeutics-deal-ill-timed-highly-dilutive,https://bit.ly/3MyfOqG
Benzinga,"Not Pretty: Bank Earnings Mostly Look Weak Compared to A Year Ago, But Bad News Baked In",https://benzinga.com/news/earnings/22/10/29268926/not-pretty-bank-earnings-mostly-look-weak-compared-to-a-year-ago-but-bad-news-baked-in,https://bit.ly/3EHLUhS
